Home > Press > Nanostart portfolio company ItN Nanovation AG publishes financial figures for 2010
Abstract:
Nanostart (OTCQX: NASRY) portfolio company ItN Nanovation AG (FSE: I7N) published its figures for the 2010 fiscal year today. The company generated revenue of €2.7 million. After adjustment for a division that has since been sold, revenue of €2.4 million was generated in the previous fiscal year. A comparative assessment adjusted for the revenue of this product group, which is no longer manufactured for strategic reasons, shows an 8.5% year-on-year increase in revenue. Revenue of €4.5 million was attained in 2009. As a result of rigorous cost discipline, earnings from operating activities were improved from €-5.9 million to €-5.3 million in 2010. At €-5.8 million, the net loss for the year also proved to be slightly more positive than the prior-year figure of €-6.1 million.
Nanostart portfolio company ItN Nanovation AG publishes financial figures for 2010
Frankfurt am Main / Saarbrücken | Posted on April 21st, 2011
In particular, ItN Nanovation achieved key strategic aims in the past fiscal year and made significant progress, especially in terms of market penetration of its ceramic flat membrane solutions, CFM systems. In the third quarter of 2010, a drinking water plant in Saudi Arabia was industrially fitted with CFM systems for the first time, replacing the conventional solution. On the basis of the superior product characteristics, ItN Nanovation soon received an additional follow-up order in the same plant complex. ItN Nanovation also carried out preparatory work in the region for a joint venture with a Saudi Arabian investor and a consortium of German industrial investors. This is set to be finalized in 2011, with a positive earnings effect of around USD 2.35 million.
Income of more than €6.3 million is likely to be generated in 2011, chiefly as a result of the income from CFM systems. A substantial increase in earnings is also planned. To ensure resources for further business development, the company is currently carrying out a cash capital increase, which ItN Nanovation expects to raise €11 million gross.
####
About Nanostart AG
Nanostart AG (OTCQX: NASRY), is the world’s leading nanotechnology investment company. Headquartered in Frankfurt am Main, it invests venture capital in nanotechnology companies in various development phases. Investments are focused on companies in the most innovation-driven segments: cleantech, life sciences and IT/electronics. Through its wholly-owned subsidiary in Singapore, Nanostart invests in nanotechnology companies in Asia in conjunction with the government of Singapore. For more information on the company, please visit www.nanostart.de.
About ItN Nanovation:
ItN Nanovation AG (FSE: I7N) is one of the world’s top nanotechnology companies. It develops innovative ceramic products such as filter systems and coatings for major industrial customers. The company manufactures the necessary nanoscale powder in-house. ItN Nanovation’s filter products can be used for drinking water treatment and wastewater purification, as filters in the drinks industry and to separate oil and water. Nanotechnology-based ceramic coatings are used as protective and catalytic layers in a wide range of applications in various industries, from ovens through aluminum foundries to coal-fired power stations. ItN Nanovation was founded in 2000. The company’s success is based on an extensive patent portfolio combined with in-depth development and application expertise. For more information on the company, please visit www.itn-nanovation.de.
Disclaimer:
This communication does not constitute an offer to sell or a request to submit an offer to buy or subscribe to securities. No initial public offering (IPO) of securities of Nanostart AG is taking place in connection with the listing of shares in the Open Market sub-segment of the Frankfurt Stock Exchange, the “Entry Standard”. This communication does not constitute a securities prospectus. This communication and the information it contains are not meant to be directly or indirectly forwarded to or within Canada, Australia or Japan.
For more information, please click here
Contacts:
Nanostart AG
Dr. Hans Joachim Duerr
Head of Corporate Communication
Goethestrasse 26-28
D-60313 Frankfurt am Main
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 150
email:
Copyright © Nanostart AG
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Long Island Capital Alliance Announces Participants for Biotech Technology Transfer Capital Forum: Event to Be Held on June 14 in Collaboration With Cold Spring Harbor Laboratory June 8th, 2013
CRIXlabs Joins the ROCK Health Incubator: ROCK Health is the world’s leading healthcare incubator looking to make meaningful change through scalable, innovative technology. June 5th, 2013
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 31st, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Financial Reports
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013
Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013
Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013